Stomach paralysis. Cyclical vomiting. Foul-smelling sulphur burps. After years of investigating the hidden costs of the ...

"We're really optimistic he's going to be able to play," Macdonald said. "Right now we're going through all the protocol, one ...

The latest update from Microsoft deals with 112 flaws, including eight the company rated critical — and three zero-day ...

Monoclonal antibodies (mAbs) aid the body against autoimmune diseases and cancer, among other things. Patients have to pick ...

BreachLock, a global leader in offensive security, today announced that its Adversarial Exposure Validation (AEV) solution ...

The three-year pilot program did not deliver the results hoped for, the health minister said. It had allowed drug users to ...

The organic light-emitting diode (OLED) technology behind flexible cell phones, curved monitors, and televisions could one ...

Last year, the US authorities approved the first at-home test that can detect three common infections in women — gonorrhea, ...

If you think SAST and SCA are enough, you’re already behind. The future of app security is posture, provenance and proof, not ...

SAN FRANCISCO, Jan 12 () - Amgen's research chief said the company is very confident about its experimental obesity drug ...

Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...